Premium
Ranolazine: novel add‐on treatment for stable angina
Author(s) -
Chaplin Steve,
Connolly Derek
Publication year - 2009
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.539
Subject(s) - ranolazine , medicine , stable angina , angina , drug , intensive care medicine , pharmacology , cardiology , coronary heart disease , myocardial infarction
Ranolazine is a new anti‐anginal drug with a novel mode of action. In our New products review, Steve Chaplin discusses the clinical data relating to its efficacy and safety, and Dr Connolly describes its place in angina management. Copyright © 2009 Wiley Interface Ltd.